Thoracic Injuries: Clinical Trials

3 trials for Thoracic Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow Thoracic Injuries: new trials by email Literature Review of Thoracic Injuries trials Research Report on Thoracic Injuries

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RAPA-501-Allo Therapy of COVID-19-ARDS
RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo - Severe COVID-19 Disease
Phase 1 / Phase 2TerminatedRapa Therapeutics LLC12020-12-302021-11-11
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
GSK2862277, Placebo - Lung Injury, Acute and Respiratory Distress Syndrome, Adult
Phase 2TerminatedGlaxoSmithKline352015-04-282020-10-27
Level of Continuous Positive Airway Pressure (CPAP) in Preterm Infants After Extubation (L-CPAP Study)
Nasal CPAP, level 7 to 9 cmH2O, Nasal CPAP, level 4 to 6 cmH2O - Respiratory Insufficiency of Prematurity
Phase 2TerminatedHamilton Health Sciences Corporation232007-07-012009-02-10

Narrower conditions

Lung Injury (3)  ·  Respiratory Distress Syndrome (3)  ·  Acute Lung Injury (1)  ·  COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Cytokine Release Syndrome (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Pneumothorax (1)  ·  Respiratory Insufficiency (1)

Broader conditions

Respiration Disorders (3)  ·  Respiratory Tract Diseases (3)  ·  Wounds and Injuries (3)  ·  Lung Diseases (2)  ·  Coronaviridae Infections (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pleural Diseases (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Infections (1)

Interventions

GSK2862277 (1)

Sponsors

GlaxoSmithKline (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Rapa Therapeutics LLC (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Daniel Fowler, M.D. (1)  ·  Giulherme M SantAnna, MD (1)

NIH funding

2014 (1)